Targeted Biotech Small team with a specialized benchtop screening solution presents an opportunity to position RSI as a flexible, cost effective partner for early-stage biotech startups and small labs looking for rapid antibody discovery and characterization.

Affordability & Speed Emphasize the ResoSens Ultra-Mab Pro platform as a rapid and label-free, high-throughput option for antibody affinity, selectivity, and specificity testing to attract budget-conscious research groups needing faster results.

Immunotherapy Alignment Customized reagents such as peptide/HLA-A2 and HLA-E monomers and tetramers present a cross-sell opportunity to immunotherapy researchers seeking specialized tools alongside the benchtop reader.

Expansion Partnership Collaborations with contract research organizations or academic labs could scale adoption, leveraging RSI’s portable system to support screening, epitope binning, and cell-based assays across multiple sites.

Digital & Global Reach Leverage existing tech stack and online presence to generate inbound interest from biotech clusters; emphasize cloud-enabled data workflows and user-friendly software to differentiate from larger, slower competitors.